We provide you with 20 years of free, institutional-grade data for ORTX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ORTX. Explore the full financial landscape of ORTX stock.
| Reported Date | CIK | Ticker | Type |
|---|
Orchard Therapeutics plc(NASDAQ:ORTX) 
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified...
Website: http://www.orchard-tx.com
Founded: 2015
Full Time Employees: 252
Sector: Healthcare
Industry: Biotechnology
The information provided in this report about ORTX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.